ProQR Therapeutics (PRQR) Net Cash Flow Growth (3y) (2016 - 2026)
ProQR Therapeutics (PRQR) Net Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | ProQR Therapeutics | 183.33 Mn | 91.04 Mn | - | -31.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.42% |
| Dec 31, 2025 | -58.99% |
| Sep 30, 2025 | 39.96% |
| Jun 30, 2025 | 7.18% |
| Mar 31, 2025 | 6.99% |
| Dec 31, 2024 | 22.08% |
| Sep 30, 2024 | -11.56% |
| Jun 30, 2024 | -28.08% |
| Mar 31, 2024 | -55.76% |
| Dec 31, 2023 | 26.61% |
| Sep 30, 2023 | -69.09% |
| Jun 30, 2023 | -5.00% |
| Mar 31, 2023 | 1,345.33% |
| Dec 31, 2022 | -28.19% |
| Sep 30, 2022 | -86.91% |
| Jun 30, 2022 | -11.42% |
| Mar 31, 2022 | -20.62% |
| Dec 31, 2021 | 1,462.70% |
| Sep 30, 2021 | -46.89% |
| Jun 30, 2021 | 132.52% |